A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

publicrestrictedorigin: hub

Last updated 9/5/2026, 12:24:12 AM

Cite this record

African DSI DataBank. A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.. AFDSI-PUB-958. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-958 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42693633/.

BibTeX

@misc{AFDSIPUB958,
  title        = {A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-958}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-958; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42693633/}
}

AFDSI-PUB-958 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.